Avalo Therapeutics, Inc. (AVTX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 243.43M |
| Enterprise Value | 230M |
| P/E Ratio | -2.66 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 7,545.32 |
| Price/Book Ratio | 0.97 |
| Enterprise/Revenue | 6,446.43 |
| Enterprise/EBITDA | -4.3 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -1,502.59 |
| Operating Margin | -1,619.61 |
| Return On Assets | -0.18 |
| Return On Equity | -0.34 |
| Revenue | 59,000 |
| Revenue/Share | 0 |
| Gross Profit | 59,000 |
| EBITDA | -77.75M |
| Net Income | -78.26M |
| Diluted EPS | -5.84 |
| Total Cash | 392.97M |
| Total Cash/Share | 7.14 |
| Total Debt | 153,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 16.63 |
| Book Value Per Share | 7.93 |
| 52-Week Change | -50.1 |
| 52-Week High | 24.27 |
| 52-Week Low | 6.53 |
| Moving Average 50 Days | 12.78 |
| Moving Average 200 Days | 15.7 |
| Average Volume | 1.69M |
| Shares Outstanding | 57.82M |
| % Held by Institutions | 162.58 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:240 |
| Last Split Date | December 29, 2023 |